Gossamer Bio
GOSS
102 hedge funds and large institutions have $155M invested in Gossamer Bio in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 15 closing their positions.
85% more call options, than puts
Call options by funds: $1.1M | Put options by funds: $598K
28% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 25
20% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 15
3% more funds holding
Funds holding: 99 → 102 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.68% less ownership
Funds ownership: 77.3% → 75.62% (-1.7%)
16% less capital inflows, than outflows
Capital inflows: $20.1M | Capital outflows: $23.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Octagon Capital Advisors
New York
|
+$7.85M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.61M |
| 3 |
Monaco Asset Management
Monaco
|
+$1.3M |
| 4 |
6CM
683 Capital Management
New York
|
+$1.01M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$991K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$6.92M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.46M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.02M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.47M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$880K |
GOSS Hedge Fund Activity: Q4 2024 in Review
102 of the 7,616 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q4 2024, worth a combined $155M — down 10% from $173M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new GOSS positions and 15 closed out — a net gain of 3 holders — while 32 added to existing stakes and 25 trimmed.
The largest buyer was Octagon Capital Advisors, adding an estimated $7.85M. The largest seller was Siren LLC, cutting an estimated $6.92M.
- 102 institutional investors held Gossamer Bio (GOSS) as of Q4 2024, up from 99 in Q3 2024.
- Funds reported $155M of Gossamer Bio stock for Q4 2024, down 10% quarter-over-quarter.
- 18 funds opened new Gossamer Bio positions in Q4 2024 and 15 closed out, a net change of +3 holders.
- The largest Gossamer Bio buyer in Q4 2024 was Octagon Capital Advisors, an estimated $7.85M added.
- The largest Gossamer Bio seller in Q4 2024 was Siren LLC, an estimated $6.92M sold.
Based on aggregated 13F filings for Q4 2024.